News Concordia and Actavis face UK pricing probe Firms colluded to hike prices, says competition watchdog.
News Pfizer under investigation over links with charities US authorities probing several other drugmakers amid pricing row.
News Biotech leaders unite against Trump travel ban Spokesman also causes confusion over pricing policy.
News Sanofi cholesterol drug can stay on US market - for now Sales of Praluent can continue during patent case appeal.
News AZ's ATR inhibitor ceralasertib flunks lung cancer test AstraZeneca has had a setback in its oncology pipeline, as AKT inhibitor ceralasertib fails to improve survival in a phase 3 lung cancer trial.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
